Literature DB >> 34130107

Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

Daniel Ferreira1, Zuzana Nedelska2, Jonathan Graff-Radford3, Scott A Przybelski4, Timothy G Lesnick4, Christopher G Schwarz5, Hugo Botha3, Matthew L Senjem6, Julie A Fields7, David S Knopman3, Rodolfo Savica3, Tanis J Ferman8, Neill R Graff-Radford9, Val J Lowe5, Clifford R Jack5, Ronald C Petersen3, Afina W Lemstra10, Marleen van de Beek10, Frederik Barkhof11, Frederic Blanc12, Paulo Loureiro de Sousa12, Nathalie Philippi12, Benjamin Cretin12, Catherine Demuynck12, Jakub Hort13, Ketil Oppedal14, Bradley F Boeve3, Dag Aarsland15, Eric Westman16, Kejal Kantarci17.   

Abstract

We investigated whether cerebrovascular disease contributes to neurodegeneration and clinical phenotype in dementia with Lewy bodies (DLB). Regional cortical thickness and subcortical gray matter volumes were estimated from structural magnetic resonance imaging (MRI) in 165 DLB patients. Cortical and subcortical infarcts were recorded and white matter hyperintensities (WMHs) were assessed. Subcortical only infarcts were more frequent (13.3%) than cortical only infarcts (3.1%) or both subcortical and cortical infarcts (2.4%). Infarcts, irrespective of type, were associated with WMHs. A higher WMH volume was associated with thinner orbitofrontal, retrosplenial, and posterior cingulate cortices, smaller thalamus and pallidum, and larger caudate volume. A higher WMH volume was associated with the presence of visual hallucinations and lower global cognitive performance, and tended to be associated with the absence of probable rapid eye movement sleep behavior disorder. Presence of infarcts was associated with the absence of parkinsonism. We conclude that cerebrovascular disease is associated with gray matter neurodegeneration in patients with probable DLB, which may have implications for the multifactorial treatment of probable DLB.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrovascular disease; Dementia with Lewy bodies (DLB); Magnetic resonance imaging; Neurodegeneration; White matter hyperintensities; infarcts

Mesh:

Year:  2021        PMID: 34130107      PMCID: PMC8338792          DOI: 10.1016/j.neurobiolaging.2021.04.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  58 in total

1.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease.

Authors:  F Fazekas; P Kapeller; R Schmidt; H Offenbacher; F Payer; G Fazekas
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

Review 2.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

Authors:  M-Marsel Mesulam
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

Review 3.  Imaging in Dementia With Lewy Bodies: An Overview.

Authors:  Rosie Watson; Sean J Colloby
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-09       Impact factor: 2.680

4.  Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

Authors:  Kejal Kantarci; Ronald C Petersen; Scott A Przybelski; Stephen D Weigand; Maria M Shiung; Jennifer L Whitwell; Selamawit Negash; Robert J Ivnik; Bradley F Boeve; David S Knopman; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2008-12

Review 5.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

6.  AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Matthew L Senjem; Nikki Tosakulwong; Timothy G Lesnick; Anthony J Spychalla; Jeffrey L Gunter; Julie A Fields; Jonathan Graff-Radford; Tanis J Ferman; David T Jones; Melissa E Murray; David S Knopman; Clifford R Jack; Ronald C Petersen
Journal:  Ann Neurol       Date:  2016-12-19       Impact factor: 10.422

7.  Microbleeds in dementia with Lewy bodies.

Authors:  Paul C Donaghy; Michael Firbank; Dipayan Mitra; George Petrides; Jim Lloyd; Nicola Barnett; Kirsty Olsen; Alan J Thomas; John T O'Brien
Journal:  J Neurol       Date:  2020-02-04       Impact factor: 4.849

8.  β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Scott A Przybelski; Timothy G Lesnick; Afina W Lemstra; Elisabet Londos; Frederic Blanc; Zuzana Nedelska; Christopher G Schwarz; Jonathan Graff-Radford; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Brit Mollenhauer; Sara Garcia-Ptacek; Carla Abdelnour; Jakub Hort; Laura Bonanni; Ketil Oppedal; Milica G Kramberger; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurology       Date:  2020-09-28       Impact factor: 9.910

9.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

Review 10.  Vascular dementia and the cholinergic pathways.

Authors:  Eliasz Engelhardt; Denise Madeira Moreira; Jerson Laks
Journal:  Dement Neuropsychol       Date:  2007 Jan-Mar
View more
  4 in total

1.  Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology.

Authors:  Ece Bayram; David G Coughlin; Irene Litvan
Journal:  Mov Disord       Date:  2022-05-09       Impact factor: 9.698

2.  Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum.

Authors:  Jon B Toledo; Hangfan Liu; Michel J Grothe; Tanweer Rashid; Lenore Launer; Leslie M Shaw; Haykel Snoussi; Susan Heckbert; Michael Weiner; John Q Trojanwoski; Sudha Seshadri; Mohamad Habes
Journal:  Alzheimers Dement (N Y)       Date:  2022-05-23

3.  Matters Arising 'Lewy body disease or diseases with Lewy bodies?'

Authors:  Kurt A Jellinger
Journal:  NPJ Parkinsons Dis       Date:  2022-06-23

4.  Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data.

Authors:  Carla Abdelnour; Daniel Ferreira; Afina W Lemstra; Eric Westman; Marleen van de Beek; Nira Cedres; Ketil Oppedal; Lena Cavallin; Frédéric Blanc; Olivier Bousiges; Lars-Olof Wahlund; Andrea Pilotto; Alessandro Padovani; Mercè Boada; Javier Pagonabarraga; Jaime Kulisevsky; Dag Aarsland
Journal:  Alzheimers Res Ther       Date:  2022-01-21       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.